Cargando…

Dendritic Self-assembled Structures from Therapeutic Charged Pentapeptides

[Image: see text] CRE(N)KA [Cys-Arg-(NMe)Glu-Lys-Ala, where (NMe)Glu refers to N-methyl-Glu], an anti-cancer pentapeptide that induces prostate tumor necrosis and significant reduction in tumor growth, was engineered to increase the resistance to endogenous proteases of its parent peptide, CREKA (Cy...

Descripción completa

Detalles Bibliográficos
Autores principales: El Hauadi, Karima, Resina, Leonor, Zanuy, David, Esteves, Teresa, Ferreira, Frederico Castelo, Pérez-Madrigal, Maria M., Alemán, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988208/
https://www.ncbi.nlm.nih.gov/pubmed/36229043
http://dx.doi.org/10.1021/acs.langmuir.2c02010
_version_ 1784901529675759616
author El Hauadi, Karima
Resina, Leonor
Zanuy, David
Esteves, Teresa
Ferreira, Frederico Castelo
Pérez-Madrigal, Maria M.
Alemán, Carlos
author_facet El Hauadi, Karima
Resina, Leonor
Zanuy, David
Esteves, Teresa
Ferreira, Frederico Castelo
Pérez-Madrigal, Maria M.
Alemán, Carlos
author_sort El Hauadi, Karima
collection PubMed
description [Image: see text] CRE(N)KA [Cys-Arg-(NMe)Glu-Lys-Ala, where (NMe)Glu refers to N-methyl-Glu], an anti-cancer pentapeptide that induces prostate tumor necrosis and significant reduction in tumor growth, was engineered to increase the resistance to endogenous proteases of its parent peptide, CREKA (Cys-Arg-Glu-Lys-Ala). Considering their high tendency to aggregate, the self-assembly of CRE(N)KA and CREKA into well-defined and ordered structures has been examined as a function of peptide concentration and pH. Spectroscopic studies and atomistic molecular dynamics simulations reveal significant differences between the secondary structures of CREKA and CRE(N)KA. Thus, the restrictions imposed by the (NMe)Glu residue reduce the conformational variability of CRE(N)KA with respect to CREKA, which significantly affects the formation of well-defined and ordered self-assembly morphologies. Aggregates with poorly defined morphology are obtained from solutions with low and moderate CREKA concentrations at pH 4, whereas well-defined dendritic microstructures with fractal geometry are obtained from CRE(N)KA solutions with similar peptide concentrations at pH 4 and 7. The formation of dendritic structures is proposed to follow a two-step mechanism: (1) pseudo-spherical particles are pre-nucleated through a diffusion-limited aggregation process, pre-defining the dendritic geometry, and (2) such pre-nucleated structures coalesce by incorporating conformationally restrained CRE(N)KA molecules from the solution to their surfaces, forming a continuous dendritic structure. Instead, no regular assembly is obtained from solutions with high peptide concentrations, as their dynamics is dominated by strong repulsive peptide–peptide electrostatic interactions, and from solutions at pH 10, in which the total peptide charge is zero. Overall, results demonstrate that dendritic structures are only obtained when the molecular charge of CRE(N)KA, which is controlled through the pH, favors kinetics over thermodynamics during the self-assembly process.
format Online
Article
Text
id pubmed-9988208
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-99882082023-03-07 Dendritic Self-assembled Structures from Therapeutic Charged Pentapeptides El Hauadi, Karima Resina, Leonor Zanuy, David Esteves, Teresa Ferreira, Frederico Castelo Pérez-Madrigal, Maria M. Alemán, Carlos Langmuir [Image: see text] CRE(N)KA [Cys-Arg-(NMe)Glu-Lys-Ala, where (NMe)Glu refers to N-methyl-Glu], an anti-cancer pentapeptide that induces prostate tumor necrosis and significant reduction in tumor growth, was engineered to increase the resistance to endogenous proteases of its parent peptide, CREKA (Cys-Arg-Glu-Lys-Ala). Considering their high tendency to aggregate, the self-assembly of CRE(N)KA and CREKA into well-defined and ordered structures has been examined as a function of peptide concentration and pH. Spectroscopic studies and atomistic molecular dynamics simulations reveal significant differences between the secondary structures of CREKA and CRE(N)KA. Thus, the restrictions imposed by the (NMe)Glu residue reduce the conformational variability of CRE(N)KA with respect to CREKA, which significantly affects the formation of well-defined and ordered self-assembly morphologies. Aggregates with poorly defined morphology are obtained from solutions with low and moderate CREKA concentrations at pH 4, whereas well-defined dendritic microstructures with fractal geometry are obtained from CRE(N)KA solutions with similar peptide concentrations at pH 4 and 7. The formation of dendritic structures is proposed to follow a two-step mechanism: (1) pseudo-spherical particles are pre-nucleated through a diffusion-limited aggregation process, pre-defining the dendritic geometry, and (2) such pre-nucleated structures coalesce by incorporating conformationally restrained CRE(N)KA molecules from the solution to their surfaces, forming a continuous dendritic structure. Instead, no regular assembly is obtained from solutions with high peptide concentrations, as their dynamics is dominated by strong repulsive peptide–peptide electrostatic interactions, and from solutions at pH 10, in which the total peptide charge is zero. Overall, results demonstrate that dendritic structures are only obtained when the molecular charge of CRE(N)KA, which is controlled through the pH, favors kinetics over thermodynamics during the self-assembly process. American Chemical Society 2022-10-13 /pmc/articles/PMC9988208/ /pubmed/36229043 http://dx.doi.org/10.1021/acs.langmuir.2c02010 Text en © 2022 American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle El Hauadi, Karima
Resina, Leonor
Zanuy, David
Esteves, Teresa
Ferreira, Frederico Castelo
Pérez-Madrigal, Maria M.
Alemán, Carlos
Dendritic Self-assembled Structures from Therapeutic Charged Pentapeptides
title Dendritic Self-assembled Structures from Therapeutic Charged Pentapeptides
title_full Dendritic Self-assembled Structures from Therapeutic Charged Pentapeptides
title_fullStr Dendritic Self-assembled Structures from Therapeutic Charged Pentapeptides
title_full_unstemmed Dendritic Self-assembled Structures from Therapeutic Charged Pentapeptides
title_short Dendritic Self-assembled Structures from Therapeutic Charged Pentapeptides
title_sort dendritic self-assembled structures from therapeutic charged pentapeptides
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988208/
https://www.ncbi.nlm.nih.gov/pubmed/36229043
http://dx.doi.org/10.1021/acs.langmuir.2c02010
work_keys_str_mv AT elhauadikarima dendriticselfassembledstructuresfromtherapeuticchargedpentapeptides
AT resinaleonor dendriticselfassembledstructuresfromtherapeuticchargedpentapeptides
AT zanuydavid dendriticselfassembledstructuresfromtherapeuticchargedpentapeptides
AT estevesteresa dendriticselfassembledstructuresfromtherapeuticchargedpentapeptides
AT ferreirafredericocastelo dendriticselfassembledstructuresfromtherapeuticchargedpentapeptides
AT perezmadrigalmariam dendriticselfassembledstructuresfromtherapeuticchargedpentapeptides
AT alemancarlos dendriticselfassembledstructuresfromtherapeuticchargedpentapeptides